Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma

The clinical management of relapsed/refractory multiple myeloma and the correct choice of the most suitable therapy in heavily pretreated and fragile patients are tough clinical issues for clinicians. In advanced phases of disease, the choice of available therapies becomes very poor, and the retreat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Case Rep Hematol
Main Authors: Cerchione, Claudio, Nappi, Davide, Di Perna, Maria, Zacheo, Irene, Pareto, Anna Emanuele, Picardi, Marco, Catalano, Lucio, Pane, Fabrizio
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2016
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5102715/
https://ncbi.nlm.nih.gov/pubmed/27867671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6745286
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki